In contrast, the PPP2R5C siRNAs not only inhibited cell proliferation but also induced apoptosis in imatinib-sensitive and imatinib-resistant CML cell lines. Here, PPP2R5C is linked to chronic myelogenous leukemia, BCR-ABL1 positive.